Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Myelodysplastic Syndromes 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid 1Leukemia, Lymphoid 1Leukemia 1Hodgkin Disease 1Graft vs Host Disease 1Anemia, Refractory, with Excess of Blasts 1Anemia, Refractory 1

Interventions

Cyclophosphamide 38Tacrolimus 35Methotrexate 29fludarabine phosphate 24Busulfan 24Cyclosporine 23Antilymphocyte Serum 23Mycophenolic Acid 20fludarabine 18Peripheral Blood Stem Cell Transplantation 18Melphalan 18Methylprednisolone 16Filgrastim 16Radiotherapy 15Sirolimus 14Whole-Body Irradiation 13thymoglobulin 8Stem Cell Transplantation 8Thiotepa 7Cord Blood Stem Cell Transplantation 7Granulocyte Colony-Stimulating Factor 6Transplantation 5Hematopoietic Stem Cell Transplantation 5Flow Cytometry 5Etoposide 5Alemtuzumab 5Cyclosporins 4Bone Marrow Transplantation 4Therapeutics 3Prednisone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Graft vs Host Disease × Photopheresis × Myeloid × Clear all
NCT01174940 2017-01-09

Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease

University of Kansas Medical Center

Phase EARLY_PHASE1 Completed
22 enrolled
LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Hodgkin Disease, Leukemia, Lymphoid, Leukemia, Myeloid, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡